Completed Access to Information Requests

Follow:

  • RSS
  • Cite
About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA). For additional information, please see the “About Access to Information Requests” webpage.

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 388 record(s)

Req # A-2023-000874

Adverse Drug Reactions (ADRs). Report numbers: 001055861, 001055864, 001055869, 001055871.

Organization: Health Canada

8 page(s)
December 2023

Req # A-2023-000876

Adverse Drug Reaction (ADR) for Morphine. Report number: E2B_06527804. ADR for Naltrexone. Report number: 001050594. ADRs for Heparin. Report numbers: 001048584, 001050673.

Organization: Health Canada

31 page(s)
December 2023

Req # A-2023-000893

Adverse Drug Reactions (ADRs). Report numbers: 000953883, 000977338, E2B_03492652, E2B_03492634, E2B_03534201, E2B_03915037, 000930082, E2B_03098071, 000943742, 000963342.

Organization: Health Canada

168 page(s)
December 2023

Req # A-2023-000910

Adverse Drug Reactions (ADRs) for Immunoglobulin (human). Report numbers: E2B_06484002, E2B_06487392, E2B_06521406. ADR for C1 Esterase Inhibitor. Report number: E2B_06524635. ADR for Antihmophilic factor (human). Report number: E2B_06490190. ADR for Prevacid. Report number: E2B_06494425. ADRs for Lansoprazole. Report numbers: 001052635, 001046431.

Organization: Health Canada

605 page(s)
December 2023

Req # A-2023-000930

Adverse Drug Reactions (ADRs). Report numbers: 001008139, 001012256, 001012304, 001014020, E2B_04005601, 000966661, E2B_05866227, E2B_04549448, E2B_05535616, E2B_05656792.

Organization: Health Canada

150 page(s)
December 2023

Req # A-2023-000949

Adverse Drug Reactions (ADRs). Report numbers: E2B_06260333, 001035819, 001035617, E2B_06244064, E2B_02790669, 001034963, 001035446, 001035583, 001035529, 001039301.

Organization: Health Canada

232 page(s)
December 2023

Req # A-2023-000955

Adverse Drug Reactions (ADRs). Report numbers: E2B_06336965, E2B_06402151, E2B_06399745, E2B_06404345, 001035620, E2B_06375857, E2B_05712679, 000954222, 000953433, 000947156.

Organization: Health Canada

130 page(s)
December 2023

Req # A-2023-000998

Adverse Drug Reactions (ADRs). Report numbers: 001025659, 001036848, E2B_06212312.

Organization: Health Canada

14 page(s)
December 2023

Req # A-2023-001037

Adverse Drug Reaction (ADR). Report number: E2B_06559459.

Organization: Health Canada

12 page(s)
December 2023

Req # A-2023-001095

Adverse Drug Reaction (ADR). Report number: 001065166.

Organization: Health Canada

1 page(s)
December 2023
Date modified: